Press Releases



All Releases
View Summary Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II
Jun 20, 2016
PDF 42.3 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation at the Jefferies 2016 Healthcare Conference
Jun 1, 2016
PDF 34.8 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Retirement Of Edward Lanphier As President And CEO; Sandy Macrae Named As Successor
Jun 1, 2016
PDF 43.6 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Participation At Upcoming Investor Conferences
May 10, 2016
PDF 36.4 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Recent Developments From Research And ZFP Therapeutic® Programs In Multiple Presentations At Annual Meeting of the American Society of Gene and Cell Therapy
May 9, 2016
PDF 45.0 KB Add to Briefcase
View Summary Sangamo BioSciences Reports First Quarter 2016 Financial Results
May 2, 2016
PDF 25.7 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The Deutsche Bank 41st Annual Health Care Conference
Apr 28, 2016
PDF 34.8 KB Add to Briefcase
View Summary Sangamo BioSciences Announces First Quarter 2016 Conference Call and Webcast
Apr 25, 2016
PDF 34.9 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentations On ZFP Therapeutic® Programs And Applications At 2016 Annual Meeting Of The American Society Of Gene & Cell Therapy
Apr 18, 2016
PDF 44.4 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Participation In The 4th Annual Cell & Gene Therapy Investor Day Meeting In New York
Mar 15, 2016
PDF 37.9 KB Add to Briefcase
View Summary Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform Programs For MPS I And MPS II At The 12th Annual WORLDSymposium™ Meeting
Mar 2, 2016
PDF 83.1 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The Cowen And Company 36th Annual Health Care Conference
Mar 1, 2016
PDF 34.9 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Phase 2 Immunological Data from SB-728-T ZFP Therapeutic® HIV Program at CROI 2016
Feb 24, 2016
PDF 90.1 KB Add to Briefcase
View Summary Sangamo BioSciences Reports Fourth Quarter And Full Year 2015 Financial Results
Feb 9, 2016
PDF 52.8 KB Add to Briefcase
View Summary Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Feb 8, 2016
PDF 42.8 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The Leerink Partners 5th Annual Global Healthcare Conference
Feb 4, 2016
PDF 34.6 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Fourth Quarter And Full Year 2015 Conference Call And Webcast
Feb 2, 2016
PDF 34.9 KB Add to Briefcase
View Summary Sangamo BioSciences Highlights 2016 Catalysts at the 34th Annual J.P. Morgan Healthcare Conference
Jan 11, 2016
PDF 40.1 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The 34th Annual J.P. Morgan Healthcare Conference
Jan 5, 2016
PDF 34.7 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Phase 2 Clinical Data From Two SB-728-T HIV Studies
Dec 11, 2015
PDF 91.3 KB Add to Briefcase
Showing 1-20 of 554 Page: 1 2 3 4 5 ... 28  Next 20
Add to Briefcase = add release to Briefcase

Stock Quote

Ticker:
SGMO
Exchange:
NASDAQ
Price:
5.77
Change:
+ 0.21
Day High:
5.81
Day Low:
5.55
Volume:
695,319
4:00 PM ET on Jun 29, 2016

Shareholder Tools